|
N.A. Moukhin, V.V. Fomin
HIV-associated nephropathy: diagnostic and treatment strategy
|
№4 / 2010
|
|
L.I. Dvoretskii
Disease and death of the Master (about M.A. Bulgakov disease)
|
№4 / 2010
|
|
O.V. Rtischeva, O.F. Kalev
Lipid metabolism parameters in haemodialysis patients: age and gender features
|
№4 / 2010
|
|
E.Yu. Ponomareva, E.V. Grigorieva, M.A. Tiapkina
Clinical course of infective endocarditis in haemodialysis patients
|
№4 / 2010
|
|
N.V. Tchebotareva, I.N. Bobkova, L.V. Kozlovskaya
Urinary excretion of nephrin as a marker of glomerulary filter deterioration in proteinuric forms of chronic glomerulonephritis
|
№4 / 2010
|
|
A.A. Demin, V.P. Drobysheva, E.S. Fridman
Kidney involvement and haemostatic disorders in infective endocarditis
|
№4 / 2010
|
|
I.M. Kutyrina, A.A. Kriachkova, S.A. Savelieva, M.V. Shestakova
Role of aldosterone in development of kidney disease in metabolic syndrome, associated with obesity
|
№4 / 2010
|
|
N.A. Novikova, G.E. Gendlin, G.I. Storojakov, N.A. Tomilina, A.M. Andrusev
Survival of patients with terminal renal failure, receiving continuous ambulatory peritoneal dialysis
|
№4 / 2010
|
|
I.E. Chazova, V.V. Fomin
European Society of Hypertension Guidelines 2009: what is changed?
|
№4 / 2010
|
|
How to improve treatment quality in patients with chronic heart failure, associated with chronic kidney disease?
|
№4 / 2010
|
|
Hyperuricemia, arterial hypertension and chronic kidney disease: interconnection and management strategy
|
№4 / 2010
|
|
*
Bright disease
|
№3 / 2010
|
Русский
